nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCB1—adrenal gland cancer	0.876	1	CbGaD
Buprenorphine—Naltrexone—ABCB1—adrenal gland cancer	0.00167	0.578	CrCbGaD
Buprenorphine—Naloxone—ABCB1—adrenal gland cancer	0.00122	0.422	CrCbGaD
Buprenorphine—CYP2C18—Metabolism—SDHD—adrenal gland cancer	0.000164	0.00135	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000161	0.00133	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000161	0.00133	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000158	0.00131	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000155	0.00128	CbGpPWpGaD
Buprenorphine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000155	0.00128	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—SDHB—adrenal gland cancer	0.000155	0.00128	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CDC42—adrenal gland cancer	0.000154	0.00128	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000154	0.00127	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000152	0.00126	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00015	0.00124	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00015	0.00124	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IGF2—adrenal gland cancer	0.000149	0.00123	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—GNAS—adrenal gland cancer	0.000148	0.00122	CbGpPWpGaD
Buprenorphine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000148	0.00122	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000144	0.00119	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—POMC—adrenal gland cancer	0.00014	0.00116	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00014	0.00115	CbGpPWpGaD
Buprenorphine—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.000137	0.00113	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000136	0.00112	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000136	0.00112	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000134	0.0011	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000134	0.0011	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000132	0.00109	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000131	0.00108	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—SDHD—adrenal gland cancer	0.00013	0.00107	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—RRM1—adrenal gland cancer	0.00013	0.00107	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000128	0.00105	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TERT—adrenal gland cancer	0.000124	0.00102	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000123	0.00101	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—POMC—adrenal gland cancer	0.000123	0.00101	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.000122	0.00101	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—MED12—adrenal gland cancer	0.000122	0.00101	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000122	0.001	CbGpPWpGaD
Buprenorphine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00012	0.000988	CbGpPWpGaD
Buprenorphine—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.000118	0.000977	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000117	0.00097	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000115	0.000953	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000114	0.000943	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000112	0.000922	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000111	0.000918	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—SDHD—adrenal gland cancer	0.00011	0.000907	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—RRM1—adrenal gland cancer	0.00011	0.000907	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—RRM1—adrenal gland cancer	0.000109	0.000899	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—SDHD—adrenal gland cancer	0.000109	0.000899	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TSHR—adrenal gland cancer	0.000108	0.000894	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—BAD—adrenal gland cancer	0.000108	0.00089	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000108	0.00089	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000107	0.000881	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000107	0.00088	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SDHB—adrenal gland cancer	0.000106	0.000874	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000106	0.000872	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.000104	0.000856	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000103	0.000854	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000103	0.00085	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000103	0.000849	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000102	0.000842	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MEN1—adrenal gland cancer	0.000102	0.000841	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000102	0.000838	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—SDHD—adrenal gland cancer	9.98e-05	0.000824	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—RRM1—adrenal gland cancer	9.98e-05	0.000824	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—POMC—adrenal gland cancer	9.94e-05	0.000821	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—BRAF—adrenal gland cancer	9.81e-05	0.00081	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CDC42—adrenal gland cancer	9.79e-05	0.000808	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	9.75e-05	0.000805	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SPRY2—adrenal gland cancer	9.75e-05	0.000805	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	9.72e-05	0.000802	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MED12—adrenal gland cancer	9.66e-05	0.000797	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	9.63e-05	0.000795	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—EGFR—adrenal gland cancer	9.51e-05	0.000785	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TSHR—adrenal gland cancer	9.5e-05	0.000784	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SDHB—adrenal gland cancer	9.45e-05	0.00078	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—GNAS—adrenal gland cancer	9.35e-05	0.000772	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	9.29e-05	0.000767	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SDHB—adrenal gland cancer	9.22e-05	0.000761	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	9.11e-05	0.000752	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	9.01e-05	0.000744	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MEN1—adrenal gland cancer	8.93e-05	0.000737	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PRKACA—adrenal gland cancer	8.91e-05	0.000736	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	8.7e-05	0.000719	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	8.69e-05	0.000717	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.63e-05	0.000713	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	8.61e-05	0.000711	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	8.33e-05	0.000688	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	8.27e-05	0.000683	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	8.24e-05	0.00068	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	8.23e-05	0.00068	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MED12—adrenal gland cancer	8.19e-05	0.000677	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MED12—adrenal gland cancer	8.12e-05	0.000671	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	8.03e-05	0.000663	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	7.94e-05	0.000656	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—POMC—adrenal gland cancer	7.91e-05	0.000653	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	7.9e-05	0.000653	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—SDHD—adrenal gland cancer	7.87e-05	0.00065	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—RRM1—adrenal gland cancer	7.87e-05	0.00065	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PRKACA—adrenal gland cancer	7.77e-05	0.000642	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	7.56e-05	0.000625	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	7.55e-05	0.000623	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MED12—adrenal gland cancer	7.44e-05	0.000615	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.44e-05	0.000614	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SDHB—adrenal gland cancer	7.36e-05	0.000608	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GNAS—adrenal gland cancer	7.22e-05	0.000596	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—POMC—adrenal gland cancer	7.18e-05	0.000593	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CTNNB1—adrenal gland cancer	7.09e-05	0.000586	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ABCB1—adrenal gland cancer	7.09e-05	0.000585	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PRKACA—adrenal gland cancer	7.05e-05	0.000582	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—POMC—adrenal gland cancer	6.93e-05	0.000573	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.9e-05	0.00057	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.89e-05	0.000569	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—RRM1—adrenal gland cancer	6.82e-05	0.000563	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SDHD—adrenal gland cancer	6.82e-05	0.000563	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PRKACA—adrenal gland cancer	6.82e-05	0.000563	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.78e-05	0.00056	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	6.77e-05	0.000559	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CDC42—adrenal gland cancer	6.59e-05	0.000544	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IGF2—adrenal gland cancer	6.36e-05	0.000525	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	6.35e-05	0.000525	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—GNAS—adrenal gland cancer	6.3e-05	0.00052	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—POMC—adrenal gland cancer	6.3e-05	0.00052	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IGF1R—adrenal gland cancer	6.14e-05	0.000507	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SDHD—adrenal gland cancer	6.09e-05	0.000503	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—RRM1—adrenal gland cancer	6.09e-05	0.000503	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PRKACA—adrenal gland cancer	5.98e-05	0.000494	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.94e-05	0.000491	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.94e-05	0.000491	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	5.93e-05	0.000489	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MED12—adrenal gland cancer	5.87e-05	0.000485	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	5.86e-05	0.000484	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.79e-05	0.000478	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CDC42—adrenal gland cancer	5.78e-05	0.000477	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	5.76e-05	0.000476	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GNAS—adrenal gland cancer	5.71e-05	0.000471	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	5.68e-05	0.000469	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—EGFR—adrenal gland cancer	5.62e-05	0.000464	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ABCB1—adrenal gland cancer	5.6e-05	0.000463	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	5.6e-05	0.000462	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	5.6e-05	0.000462	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.59e-05	0.000462	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF2—adrenal gland cancer	5.57e-05	0.00046	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	5.55e-05	0.000458	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	5.55e-05	0.000458	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—GNAS—adrenal gland cancer	5.52e-05	0.000456	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	5.43e-05	0.000448	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF1R—adrenal gland cancer	5.39e-05	0.000445	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.36e-05	0.000443	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	5.32e-05	0.000439	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TERT—adrenal gland cancer	5.29e-05	0.000437	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MED12—adrenal gland cancer	5.09e-05	0.00042	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	4.89e-05	0.000403	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—POMC—adrenal gland cancer	4.86e-05	0.000402	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GNAS—adrenal gland cancer	4.84e-05	0.0004	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GNAS—adrenal gland cancer	4.8e-05	0.000397	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ABCB1—adrenal gland cancer	4.75e-05	0.000393	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	4.74e-05	0.000392	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	4.74e-05	0.000392	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TP53—adrenal gland cancer	4.72e-05	0.00039	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	4.71e-05	0.000389	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	4.71e-05	0.000389	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	4.67e-05	0.000386	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TERT—adrenal gland cancer	4.64e-05	0.000383	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—BAD—adrenal gland cancer	4.6e-05	0.00038	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	4.55e-05	0.000376	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.55e-05	0.000375	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MED12—adrenal gland cancer	4.54e-05	0.000375	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.5e-05	0.000372	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MED12—adrenal gland cancer	4.43e-05	0.000366	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GNAS—adrenal gland cancer	4.4e-05	0.000363	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	4.32e-05	0.000357	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	4.28e-05	0.000354	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—POMC—adrenal gland cancer	4.24e-05	0.00035	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—BRAF—adrenal gland cancer	4.19e-05	0.000346	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MED12—adrenal gland cancer	4.17e-05	0.000345	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MED12—adrenal gland cancer	4.14e-05	0.000342	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—EGFR—adrenal gland cancer	4.06e-05	0.000335	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.06e-05	0.000335	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—BAD—adrenal gland cancer	4.03e-05	0.000333	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	3.92e-05	0.000324	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—adrenal gland cancer	3.88e-05	0.00032	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—POMC—adrenal gland cancer	3.84e-05	0.000317	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—POMC—adrenal gland cancer	3.72e-05	0.000307	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	3.71e-05	0.000306	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.7e-05	0.000305	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—BRAF—adrenal gland cancer	3.67e-05	0.000303	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.66e-05	0.000302	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.66e-05	0.000302	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.63e-05	0.000299	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	3.56e-05	0.000294	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MED12—adrenal gland cancer	3.54e-05	0.000292	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GNAS—adrenal gland cancer	3.47e-05	0.000287	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	3.41e-05	0.000282	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	3.41e-05	0.000281	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	3.31e-05	0.000273	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—POMC—adrenal gland cancer	3.26e-05	0.000269	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.24e-05	0.000267	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—POMC—adrenal gland cancer	3.23e-05	0.000267	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.23e-05	0.000267	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.16e-05	0.000261	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	3.14e-05	0.00026	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	3.1e-05	0.000256	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—adrenal gland cancer	3.07e-05	0.000253	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	3.05e-05	0.000251	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.03e-05	0.00025	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	3.02e-05	0.000249	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	3.01e-05	0.000248	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GNAS—adrenal gland cancer	3.01e-05	0.000248	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—POMC—adrenal gland cancer	2.96e-05	0.000245	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.95e-05	0.000244	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	2.95e-05	0.000244	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.73e-05	0.000225	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	2.68e-05	0.000222	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.65e-05	0.000219	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.63e-05	0.000217	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.62e-05	0.000216	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—adrenal gland cancer	2.6e-05	0.000215	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	2.58e-05	0.000213	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	2.58e-05	0.000213	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.52e-05	0.000208	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.47e-05	0.000204	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	2.45e-05	0.000202	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.42e-05	0.0002	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	2.4e-05	0.000198	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	2.4e-05	0.000198	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	2.36e-05	0.000195	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—POMC—adrenal gland cancer	2.34e-05	0.000193	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.24e-05	0.000185	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	2.1e-05	0.000174	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	2.09e-05	0.000173	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	2.05e-05	0.000169	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—POMC—adrenal gland cancer	2.02e-05	0.000167	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	2.01e-05	0.000166	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.99e-05	0.000164	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	1.86e-05	0.000154	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.81e-05	0.000149	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.78e-05	0.000147	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	1.77e-05	0.000146	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.76e-05	0.000146	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.66e-05	0.000137	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.65e-05	0.000136	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	1.61e-05	0.000133	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.61e-05	0.000133	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.58e-05	0.000131	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	1.49e-05	0.000123	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.44e-05	0.000119	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—POMC—adrenal gland cancer	1.41e-05	0.000116	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.41e-05	0.000116	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.33e-05	0.000109	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	1.31e-05	0.000109	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	1.12e-05	9.27e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.09e-05	8.97e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	8.67e-06	7.16e-05	CbGpPWpGaD
